Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELOVL1 |
| Upstream (Parents) |
|---|
| (<<) ALDOA → ELOVL1 |
| (<<) ANXA2 → ELOVL1 |
| (<<) CSTB → ELOVL1 |
| (<<) EPHA2 → ELOVL1 |
| (<<) PHLDA2 → ELOVL1 |
| (<<) RPS6KA1 → ELOVL1 |
| (<<) S100P → ELOVL1 |
| (<<) SFN → ELOVL1 |
| (<<) TMSB10 → ELOVL1 |
| (<<) YWHAZ → ELOVL1 |
| Downstream (Children) |
|---|
| ELOVL1 → CAMKK2 (>>) |
| ELOVL1 → CCL24 (>>) |
| ELOVL1 → CCNL1 (>>) |
| ELOVL1 → CLCF1 (>>) |
| ELOVL1 → CSNK1E (>>) |
| ELOVL1 → E2F2 (>>) |
| ELOVL1 → FOSL1 (>>) |
| ELOVL1 → GNG12 (>>) |
| ELOVL1 → GNG5 (>>) |
| ELOVL1 → ISG20 (>>) |
| ELOVL1 → ITGB8 (>>) |
| ELOVL1 → KHDRBS1 (>>) |
| ELOVL1 → MAP2K1 (>>) |
| ELOVL1 → MAP3K6 (>>) |
| ELOVL1 → NBL1 (>>) |
| ELOVL1 → PITPNC1 (>>) |
| ELOVL1 → PLCH2 (>>) |
| ELOVL1 → PSORS1C2 (>>) |
| ELOVL1 → PTPLA (>>) |
| ELOVL1 → RHOC (>>) |
| ELOVL1 → UPP1 (>>) |
| ELOVL1 → VANGL1 (>>) |
| ELOVL1 → YRDC (>>) |
